Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular Diseases

by Business Wire • 2022/07/19 • 0 Comments

PITTSBURGH--(BUSINESS WIRE)--Avista today announced a partnership with Roche to develop novel AAV gene therapy vectors for the eyes.